semaglutide sublingual / BioLingus - LARVOL DELTA

Galmed Signed Term Sheet for the Development of Novel Semaglutide Sublingual Formulation (PRNewswire) - "Galmed Pharmaceuticals Ltd...announced today that it has signed a binding term-sheet with Entomus s.r.o. for a license agreement for the development and commercialization of a proprietary Self-Emulsifying Drug Delivery System (SEDDS) formulation that allows absorption of sublingually administrated peptides such as GLP-1 (Semaglutide, Liraglutide etc.). A definitive agreement determining, among other things, the milestones payments and future royalty payments is to be executed within ninety (90) days."

Licensing / partnership • Diabetes • Metabolic Disorders • Obesity